Table I. HLA-A and HER family expression on ESCC and gastric cancer cell lines
Flow Cytometry (MFI)
Cell LinesHLA-A AlleleHLA-A02HLA-A24HER1HER2HER3
ESCC
 TE12402, 2601(−)36.2122.585.223.0
 TE20206399.8(−)74.744.727.7
 TE30206944.4(−)207.334.030.5
 TE40207, 110150.9(−)31.2577.448.0
 TE502061736.1(−)158.179.427.6
 KYSE300206, 2402231.517.8365.399.164.9
 KYSE500206247.9(−)147.565.627.1
 KYSE1100206202.2(−)69.820.526.4
Gastric cancer
 MKN72402(−)31.9156.4970.023.2
 NCI-N872301(−)518.6a73.12737.130.8
 KATOIII0201, 02071309.8(−)62.2247.551.7
 OE19020173.7(−)36.9774.885.4
 NUGC32402(−)76.688.345.524.5
 NUGC20207, 2404104.924.3ND217.5ND
Breast cancer
 BT4740101, 2902(−)(−)14.5565.3ND
Epidermoid carcinoma
 A4310301(−)(−)421.3134.8ND
  • a Anti–HLA-A24 mAb cross-reacts with the HLA-A23 molecule.

  • (−), Negative expression; ND, not determined.